Sigrid Therapeutics AB
Sweden
- Stockholm
- 20/01/2023
- Unknown
- $580,679
Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide. Each year 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease.
Sigrid is a clinical-stage biotech company driven by the vision to improve human health through material-based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely and effectively.
- Industry Medical Equipment Manufacturing
- Website https://www.sigridthx.com/
- LinkedIn https://www.linkedin.com/company/sigrid-therapeutics-ab/
Related People
Sana AlajmovicCo Founder
Sweden -
Greater Stockholm Metropolitan Area
Entrepreneur with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Operations Management, Sales, Entrepreneurship, and International Business. Strong business development professional with a BSc Program in Business and Economcis focused in Economics and Marketing from Stockholm School of Economics.
Maritime Fusion | $4,500,000 | (Nov 25, 2025)
Opti | $20,000,000 | (Nov 25, 2025)
Cordance Medical | $8,000,000 | (Nov 25, 2025)
AI One | $7,000,000 | (Nov 25, 2025)
Redrob | $10,000,000 | (Nov 25, 2025)
Pibit.AI | $7,000,000 | (Nov 25, 2025)
Votre | $3,750,000 | (Nov 25, 2025)
Tidalwave | $22,000,000 | (Nov 25, 2025)
Relixir | $2,000,000 | (Nov 25, 2025)
Interface | $3,500,000 | (Nov 25, 2025)
Model ML | $75,000,000 | (Nov 25, 2025)
Mirantus Health | $6,338,062 | (Nov 25, 2025)